In this issue:
- Influenza vaccine fact sheets – information about this year’s influenza vaccines
- An important change to manage a cold chain breach for influenza vaccine
- Influenza co-administered with other vaccines
- Human Papillomavirus dose recommendations
- Updated meningococcal fact sheets from the NCIRS
The National Centre for Immunisation Research and Surveillance (NCIRS) has two updated fact sheets:
- Influenza vaccines for Australians
- Influenza vaccines - frequently asked questions.
These resources include detailed information about the 2018 seasonal influenza vaccines, including the 'enhanced' vaccines for people aged 65 years and over.
Influenza vaccines – frequently asked questions, raises common questions and responses.
Download and display a range of fact sheets and posters about influenza vaccine for Aboriginal and Torres Strait Islander people and for pregnancy plus resources for vaccine providers.
Fluad trivalent influenza vaccine is a risk to patients with latex allergy.
All cold chain breaches involving seasonal influenza vaccine outside the recommended range of 2°C to 8°C, excluding fluctuations up to 12°C lasting no longer than 15 minutes must be managed as follows:
Always contact the manufacturer for guidance with every cold chain breach involving seasonal influenza vaccine:
Use the current Government vaccine order form when ordering your 2018 seasonal influenza vaccine.
Influenza co-administered with other vaccines
All influenza vaccines can be administered concurrently with any other vaccine, including pneumococcal polysaccharide vaccine, zoster vaccine and all scheduled childhood vaccines.
Parents/carers of infants or children who are recommended to receive both influenza vaccine and 13-valent pneumococcal conjugate vaccine should be advised of a possible small increased risk of fever following concomitant administration of these vaccines.
The Australian Immunisation Handbook, chapter 4.7 Influenza, has been updated with the 2018 influenza information.
New dose recommendations for Gardasil9® (9vHPV) from the updated Australian Immunisation Handbook chapter 4.6 Human Papillomavirus:
- All individuals (males and females) who commence vaccination at the age of 9 to 14 years, except immucompromised individuals (refer to (b) below), should receive 2 doses of 9vHPV vaccine given 6-12 months apart (0, 6-12 months).
- The following population groups should receive 3 doses of 9vHPV vaccine given at 0, 2 and 6 months:
- immunocompromised individuals (males and females) at any age;
- males and females who receive their first dose of 9vHPV after turning 15 years of age.
Download the March 2018 Immunisation schedule Victoria for adolescent vaccine recommendations.
The following factsheets have been updated and are available on the National Centre for Immunisation Research and Surveillance website:
- Meningococcal vaccines for Australians factsheet
- Meningococcal vaccines – frequently asked questions
The updates include the latest information on jurisdictional programs and information on a newly registered Meningococcal B vaccine, Trumenba®.
Meningococcal vaccines – frequently asked questions focuses on the quadrivalent A,C,W,Y conjugate vaccines.
Review the current AusVaxSafety surveillance data for HPV, zoster, pertussis and influenza vaccinations.
Subscribe to the Australian Immunisation Professionals Network (NCIRS-AIP) – join a private group of professionals working in the area of immunisation. Keep up to date with vaccine news and meetings of interest.
The Victorian Government’s new flu campaign follows 12 ordinary Victorians sharing their experiences of the flu. The message is clear - you never forget the flu, so don't forget your flu shot. Posters will be delivered to all immunisation providers in the coming weeks as well as additional resources available via a digital toolkit.